Author:
Ntabadde Kauthrah,Kagaayi Joseph,Ssempijja Victor,Feng Xinyi,Kairania Robert,Lubwama Joseph,Ssekubugu Robert,Yeh Ping Teresa,Ssekasanvu Joseph,Tobian Aaron A R,Kennedy Caitlin E.,Mills Lisa A.,Alamo Stella,Kreniske Philip,Santelli John,Nelson Lisa J.,Reynolds Steven J.,Chang Larry William,Nakigozi Gertrude,Grabowski M. Kate
Abstract
ABSTRACTBackgroundThere are limited population-level data on the pre-exposure prophylaxis (PrEP) care continuum in eastern Africa. Here, we assessed the PrEP care continuum following PrEP rollout in a Ugandan community with ∼40% HIV seroprevalence.MethodsWe used cross-sectional population-based data collected between September 3 and December 19, 2018 from a Lake Victoria fishing community in southern Uganda to measure levels of self-reported PrEP knowledge, ever use, and discontinuation following 2017 PrEP rollout via a U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)-supported phased implementation program. Our analysis included HIV-seronegative persons reporting having ever received an HIV test result. We examined associations between demographic, behavioral, and health utilization factors with each outcome using age-adjusted modified Poisson regression.ResultsThere were 1,401 HIV-seronegative participants, of whom 1,363 (97.3%) reported ever receiving an HIV test result. Median age was 29 years (IQR: 23-36), and 42.3% (n=577) were women. Most (85.5%; n=1,166) participants reported PrEP knowledge, but few (14.5%; n=197) reported ever using PrEP. Among 375 (47.7%) men and 169 (29.3%) women PrEP-eligible at time of survey, 18.9% (n=71) and 27.8% (n=47) reported ever using PrEP, respectively. Over half (52.3%, n=103) of those who had ever used PrEP, self-reported current use.ConclusionIn this Lake Victoria fishing community, there were low levels of PrEP use despite high levels of PrEP awareness and eligibility, particularly among men. Efforts that enhance awareness of HIV risk and increase PrEP accessibility may help increase PrEP use among HIV-seronegative persons in African settings with high HIV burden.
Publisher
Cold Spring Harbor Laboratory
Reference39 articles.
1. UNAIDS_FactSheet_en.pdf [Internet]. [cited 2022 Jan 8]. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
2. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV [Internet]. [cited 2022 Jul 5]. Available from: https://www.who.int/publications-detail-redirect/9789241509565
3. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
4. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
5. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana